These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1179 related items for PubMed ID: 19427095

  • 21. Obstetric risk factors associated with placenta previa development: case-control study.
    Tuzović L, Djelmis J, Ilijić M.
    Croat Med J; 2003 Dec; 44(6):728-33. PubMed ID: 14652887
    [Abstract] [Full Text] [Related]

  • 22. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation.
    Tang OS, Chan CC, Kan AS, Ho PC.
    Hum Reprod; 2005 Nov; 20(11):3062-6. PubMed ID: 16037110
    [Abstract] [Full Text] [Related]

  • 23. Previous abortion and the risk of low birth weight and preterm births.
    Brown JS, Adera T, Masho SW.
    J Epidemiol Community Health; 2008 Jan; 62(1):16-22. PubMed ID: 18079328
    [Abstract] [Full Text] [Related]

  • 24. Misoprostol for termination of mid-trimester post-Caesarean pregnancy.
    Bhattacharjee N, Ganguly RP, Saha SP.
    Aust N Z J Obstet Gynaecol; 2007 Feb; 47(1):23-5. PubMed ID: 17261095
    [Abstract] [Full Text] [Related]

  • 25. Risk of late first and second trimester miscarriage after induced abortion.
    Bracken MB, Bryce-Buchanan C, Srisuphan W, Holford TR, Silten R.
    Am J Perinatol; 1986 Apr; 3(2):84-91. PubMed ID: 3964388
    [Abstract] [Full Text] [Related]

  • 26. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.
    Rose SB, Shand C, Simmons A.
    Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051
    [Abstract] [Full Text] [Related]

  • 27. The effect of oral versus vaginal misoprostol on cervical dilatation in first-trimester abortion: a double-blind, randomized study.
    Inal MM, Ertopçu K, Arici A, Ozelmas I.
    Eur J Contracept Reprod Health Care; 2003 Dec; 8(4):197-202. PubMed ID: 15006266
    [Abstract] [Full Text] [Related]

  • 28. Success rate of second-trimester termination of pregnancy using misoprostol.
    Prachasilpchai N, Russameecharoen K, Borriboonhirunsarn D.
    J Med Assoc Thai; 2006 Aug; 89(8):1115-9. PubMed ID: 17048418
    [Abstract] [Full Text] [Related]

  • 29. Previous history of surgically induced abortion and complications of the third stage of labour in subsequent normal vaginal deliveries.
    Haldre K, Rahu K, Karro H, Rahu M.
    J Matern Fetal Neonatal Med; 2008 Dec; 21(12):884-8. PubMed ID: 19065460
    [Abstract] [Full Text] [Related]

  • 30. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
    Gemzell-Danielsson K, Lalitkumar S.
    Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097
    [Abstract] [Full Text] [Related]

  • 31. Second-trimester loss and subsequent pregnancy outcomes: What is the real risk?
    Edlow AG, Srinivas SK, Elovitz MA.
    Am J Obstet Gynecol; 2007 Dec; 197(6):581.e1-6. PubMed ID: 18060941
    [Abstract] [Full Text] [Related]

  • 32. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
    Chai J, Tang OS, Hong QQ, Chen QF, Cheng LN, Ng E, Ho PC.
    Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993
    [Abstract] [Full Text] [Related]

  • 33. Is induced abortion a risk factor in subsequent pregnancy?
    Voigt M, Henrich W, Zygmunt M, Friese K, Straube S, Briese V.
    J Perinat Med; 2009 Feb; 37(2):144-9. PubMed ID: 18976047
    [Abstract] [Full Text] [Related]

  • 34. Induced abortion and risk of small-for-gestational-age birth.
    Parazzini F, Cipriani S, Chiaffarino F, Sandretti F, Bortolus R, Chiantera V.
    BJOG; 2007 Nov; 114(11):1414-8. PubMed ID: 17803719
    [Abstract] [Full Text] [Related]

  • 35. First-trimester pregnancy termination with 800 microg of vaginal misoprostol every 12 h.
    Salakos N, Kountouris A, Botsis D, Rizos D, Gregoriou O, Detsis G, Creatsas G.
    Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):249-54. PubMed ID: 16448952
    [Abstract] [Full Text] [Related]

  • 36. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial.
    Caliskan E, Doger E, Cakiroglu Y, Corakci A, Yucesoy I.
    Eur J Contracept Reprod Health Care; 2009 Feb; 14(1):55-60. PubMed ID: 19241302
    [Abstract] [Full Text] [Related]

  • 37. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy.
    Donders GG, Van Calsteren K, Bellen G, Reybrouck R, Van den Bosch T, Riphagen I, Van Lierde S.
    BJOG; 2009 Sep; 116(10):1315-24. PubMed ID: 19538417
    [Abstract] [Full Text] [Related]

  • 38. Risk factors for previable premature rupture of membranes or advanced cervical dilation: a case control study.
    Kilpatrick SJ, Patil R, Connell J, Nichols J, Studee L.
    Am J Obstet Gynecol; 2006 Apr; 194(4):1168-74; discussion 1174-5. PubMed ID: 16580325
    [Abstract] [Full Text] [Related]

  • 39. Therapeutic termination of second trimester pregnancies with low dose misoprostol.
    Liaquat NF, Javed I, Shuja S, Shoaib T, Bano K, Waheed S, Ansar A.
    J Coll Physicians Surg Pak; 2006 Jul; 16(7):464-7. PubMed ID: 16827957
    [Abstract] [Full Text] [Related]

  • 40. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
    Carbonell JL, Gallego FG, Llorente MP, Bermudez SB, Sala ES, González LV, Texido CS.
    Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.